Twitter threatens legal action over Meta’s new app & more…Keep up with what has been happening this week in our latest IP news round-up…
Meta, Microsoft, hundreds more own trademarks to new Twitter name
Billionaire Elon Musk’s decision to rebrand Twitter as X could be complicated legally: companies including Meta and Microsoft already have intellectual property rights to the same letter.
Threads: Twitter threatens legal action over Meta’s new app
Twitter is considering legal action against Meta over its fast-growing rival app Threads.
Here’s what AbbVie doesn’t want you to know about its sham AndroGel patent case
Any way you look at it, AbbVie predecessor Abbott Laboratories made a bad decision when it sued generic drug maker Perrigo in 2011, as Perrigo geared up to bring a generic version of AbbVie’s testosterone replacement product AndroGel to market.
Mewburn Ellis is proud to work on 18 of the 50 top-selling pharmaceuticals of 2022
Last year Mewburn Ellis reported the unprecedented growth of the innovative pharmaceuticals industry in 2021 and the close involvement they had with some of the blockbuster drugs that drove this success. They are delighted to release our latest report on the figures for 2022.
We are pleased to announce that our partner and the head of our Maucher Jenkins China offices, Handong Ran, has been recognised by IPRDaily as a leading intellectual property figure in Guangdong-Hong Kong-Macao Greater Bay Area in the year 2021-2022.
Marks & Spencer win latest IP supermarket IP battle against Aldi
Following the IP dispute between M&S and Aldi over their competing caterpillar cakes, Judge Hacon has ruled in an IPEC decision ([2023] EWHC 178 (IPEC)) that Aldi’s Infusionist gin bottles infringe M&S’s registered designs for its snow-globe themed gin bottles.
